We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Reorganizes Regulatory Office to Handle Drug Industry Globalization
FDA Reorganizes Regulatory Office to Handle Drug Industry Globalization
September 26, 2012
The FDA is planning to reorganize its Office of Regulatory Affairs (ORA), including creating new offices and reorganizing others, as it takes steps to dissolve cumbersome domestic and international distinctions and to keep up with increasingly global operations.